Astraea
Astraea is a YC Spring 2026 (P26) company. Based in San Francisco, CA, USA. Team of 2.
About Astraea
Summary
Astraea automates clinical trial biometrics for Phase II/III pharma and biotech sponsors, taking studies from raw data inputs to FDA-ready submission packages. The platform covers SDTM and ADaM dataset generation, Define-XML, tables/figures/listings, QC, and revision workflows in a single auditable pipeline, replacing months of manual statistical programming and data management work done by CROs or in-house biometrics teams.
Business model
Astraea offers a platform sponsors run in their own environment, with an option for expert-operated deployment.
Go-to-market
Pharma and biotech sponsors ranging from emerging biotechs to top global pharma companies are the buyers, reached through direct sales and a demo-request flow on the website.
From the Y Combinator listing
AI Operating System for Clinical Development
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.
Facts
- B2B / B2B
- San Francisco, CA, USA
- 2
- Active
- Early
Founders (2)
- Joshua Wang
- Sanmay Sarada
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works